Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results


1.		A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 to5				Pharmaceutical / Industry				1839IL/0143 NCT00234429

Last Modified: 5/14/2007 First Published: 12/1/1996


2.		Phase III Randomized Study of Leucovorin and Fluorouracil Versus Continuous-Infusion Fluorouracil Versus ICI D1694 as Palliative Therapy for Advanced Colorectal Cancer, With a Second Randomization in Stable and Responding Patients for Continued Chemotherapy Versus Observation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified								MRC-CR06 EU-96049, NCT00002893

Last Modified: 8/14/2007 First Published: 8/1/1998


3.		Phase III Randomized Study of Raltitrexed Versus Standard Leucovorin Calcium-Modulated Bolus Fluorouracil for Stage III Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								EORTC-40962 PETACC-1

Last Modified: 12/20/2007 First Published: 3/1/2000


4.		Phase III Randomized Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Over 18				Other				EORTC-08983 NCT00004920

Last Modified: 7/18/2006


5.		Phase II Study of ICI D1694, a Thymidylate Synthase Inhibitor, for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				E-6293 E6293

Last Modified: 6/1/1999


6.		Phase II Study of ICI D1694 for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				adult				NCI				SWOG-9519 SWOG-9519

Last Modified: 8/1/1999


7.		Phase II Study of ICI D1694 (a Thymidylate Synthase Inhibitor) for Advanced Hormone-Refractory Prostate Cancer (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				NCCTG-935251 NCCTG-93-52-51

Last Modified: 3/1/1998 First Published: 12/1/1997


8.		Phase II Study of Raltitrexed (Tomudex) in Adult Recurrent Metastatic Soft Tissue Sarcomas (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15-75				Pharmaceutical / Industry				EORTC-62951

Last Modified: 2/6/2007 First Published: 2/1/2000


9.		Phase II Study of Raltitrexed in Patients With Inoperable Malignant Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18								EORTC-08992 NCT00004254

Last Modified: 7/1/1993


10.		Phase II Study of ICI D1694, a Thymidylate Synthase Inhibitor, in Patients with Pancreatic or Gastric Adenocarcinoma (Summary Last Modified 07/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								MSKCC-93019 NCI-V93-0246

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute